Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-067648

Director bought 18,000 shares at $1.40 ($25,200)

From the SEC's structured data for this filing

Trades in this filing

Sukhtian Faisal Ghiath · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-02 Purchase : show line 1 in the form +18,000 $1.40 $25,200 38,000 D
Open-market purchases · 18,000 sh · avg $1.40 · $25,200
Loading xslF345X03/doc4.xml…